Literature DB >> 29169710

Dysmetabolic iron overload syndrome (DIOS).

Yves Deugnier1, Édouard Bardou-Jacquet2, Fabrice Lainé3.   

Abstract

Dysmetabolic iron overload syndrome (DIOS) corresponds to mild increase in both liver and body iron stores associated with various components of metabolic syndrome in the absence of any identifiable cause of iron excess. It is characterized by hyperferritinemia with normal or moderately increased transferrin saturation, one or several metabolic abnormalities (increased body mass index with android distribution of fat, elevated blood pressure, dyslipidaemia, abnormal glucose metabolism, steatohepatitis), and mild hepatic iron excess at magnetic resonance imaging or liver biopsy. Alteration of iron metabolism in DIOS likely results from a multifactorial and dynamic process triggered by an excessively rich diet, facilitated by environmental and genetic cofactors and implying a cross-talk between the liver and visceral adipose tissue. Phlebotomy therapy cannot be currently considered as a valuable option in DIOS patients. Sustained modification of diet and life-style habits remains the first therapeutic intervention in these patients together with drug control of increased blood pressure, abnormal blood glucose and dyslipidaemia when necessary.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 29169710     DOI: 10.1016/j.lpm.2017.05.036

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  12 in total

1.  Roux-en-Y Gastric Bypass as a Treatment for Hepatic Iron Overload: An Exploratory Study.

Authors:  Rafael Nascimento de Jesus; Guilherme Hoverter Callejas; Felipe David Mendonça Chaim; Martinho Antonio Gestic; Murillo Pimentel Utrini; Francisco Callejas-Neto; Elinton Adami Chaim; Everton Cazzo
Journal:  Obes Surg       Date:  2022-05-11       Impact factor: 3.479

2.  Association of Metabolic Syndrome and Hyperferritinemia in Patients at Cardiovascular Risk.

Authors:  Ricardo José Tofano; Leticia Maria Pescinni-Salzedas; Eduardo Federighi Baisi Chagas; Claudia Rucco Penteado Detregiachi; Elen Landgraf Guiguer; Adriano Cressoni Araujo; Marcelo Dib Bechara; Claudio José Rubira; Sandra Maria Barbalho
Journal:  Diabetes Metab Syndr Obes       Date:  2020-09-24       Impact factor: 3.168

3.  Measurement of liver iron by magnetic resonance imaging in the UK Biobank population.

Authors:  Andy McKay; Henry R Wilman; Andrea Dennis; Matt Kelly; Michael L Gyngell; Stefan Neubauer; Jimmy D Bell; Rajarshi Banerjee; E Louise Thomas
Journal:  PLoS One       Date:  2018-12-21       Impact factor: 3.240

4.  Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration.

Authors:  Henry R Wilman; Constantinos A Parisinos; Naeimeh Atabaki-Pasdar; Matt Kelly; E Louise Thomas; Stefan Neubauer; Anubha Mahajan; Aroon D Hingorani; Riyaz S Patel; Harry Hemingway; Paul W Franks; Jimmy D Bell; Rajarshi Banerjee; Hanieh Yaghootkar
Journal:  J Hepatol       Date:  2019-06-19       Impact factor: 25.083

5.  Serum Ferritin Independently Predicts the Incidence of Chronic Kidney Disease in Patients with Type 2 Diabetes Mellitus.

Authors:  Yun Hong Wu; Su Yuan Wang; Ming Xia Li; Hua He; Wei Jin Yin; Yan Hong Guo; Hui Qin Zhang; Zeng Mei Sun; Dan Zhang; Xi Wang; Shu Yao Sun; Shu Xi Tang; Rong Du; Cheng Hui Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2020-01-14       Impact factor: 3.168

Review 6.  Revisiting hemochromatosis: genetic vs. phenotypic manifestations.

Authors:  Gregory J Anderson; Edouard Bardou-Jacquet
Journal:  Ann Transl Med       Date:  2021-04

Review 7.  Iron Reshapes the Gut Microbiome and Host Metabolism.

Authors:  Amy Botta; Nicole G Barra; Nhat Hung Lam; Samantha Chow; Kostas Pantopoulos; Jonathan D Schertzer; Gary Sweeney
Journal:  J Lipid Atheroscler       Date:  2021-03-10

8.  Dysregulated Iron Metabolism-Associated Dietary Pattern Predicts an Altered Body Composition and Metabolic Syndrome.

Authors:  Anggun Rindang Cempaka; Sung-Hui Tseng; Kuo-Ching Yuan; Chyi-Huey Bai; Alexey A Tinkov; Anatoly V Skalny; Jung-Su Chang
Journal:  Nutrients       Date:  2019-11-11       Impact factor: 5.717

Review 9.  The Other Obesity Epidemic-Of Drugs and Bugs.

Authors:  Adonis Sfera; Carolina Osorio; Eddie Lee Diaz; Gerald Maguire; Michael Cummings
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-31       Impact factor: 5.555

Review 10.  Regulatory Connections between Iron and Glucose Metabolism.

Authors:  Carine Fillebeen; Nhat Hung Lam; Samantha Chow; Amy Botta; Gary Sweeney; Kostas Pantopoulos
Journal:  Int J Mol Sci       Date:  2020-10-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.